Universidade Federal de Minas Gerais
Welcome,         Profile    Billing    Logout  
 2 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Teixeira, Mauro M
NCT04650399: A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents

Completed
3
750
RoW
Active, Placebo
Butantan Institute, Valneva Austria GmbH
Chikungunya
02/23
02/24
NCT03927131: Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine

Active, not recruiting
3
5822
RoW
QIV-IB, TIVV-IB, TIVY-IB, QIV-IB Lot A, QIV-IB Lot B, QIV-IB Lot C
Butantan Institute, Butantan Foundation
Influenza, Human
07/23
10/24
PLATCOV, NCT05041907: Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19

Recruiting
2
3800
RoW
Nirmatrelvir/ritonavir (e.g. PAXLOVID™), Nitazoxanide, Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™), Hydroxychloroquine, No treatment, Monoclonal antibodies, Fluoxetine, Molnupiravir, Sotrovimab, Ensitrelvir, Favipiravir, Ivermectin, Remdesivir, Atilotrelvir/ritonavir, Metformin, Nirmatrelvir/ritonavir, Nirmatrelvir
University of Oxford
COVID-19
01/27
01/27
AD ASTRA, NCT05648448: A Phase 2 Trial Comparing Antiviral Treatments in Early Symptomatic Influenza

Recruiting
2
3000
RoW
Oseltamivir, Favipiravir, Zanamivir, Baloxavir, Molnupiravir, Peramivir, Laninamivir, Oseltamivir and Baloxavir, Oseltamivir and Favipiravir, Favipiravir and Baloxavir
University of Oxford
Influenza, Influenza, Human
01/27
01/27
AVISA, NCT04355338: Assessment of Incidence of SARS-CoV-2 Infection and COVID-19 in Brazil

Completed
N/A
3520
RoW
Butantan Institute
COVID-19
10/21
10/24

Download Options